Innoviva (INVA) Stock: Charts & Financials

Innoviva, Inc.(INVA)

Biotechnology · Burlingame, CA

$20.90+0.26 (+1.26%)

Delayed quote: Oct 6, 2026, 1:25 PM EDT

About Innoviva, Inc.

Innoviva, Inc. functions as a pharmaceutical company, concentrating on the worldwide creation and marketing of medical treatments. Its current product lineup prominently includes several once-daily combination therapies: RELVAR/BREO ELLIPTA, which integrates vilanterol (a long-acting beta2 agonist, or LABA) with fluticasone furoate (an inhaled corticosteroid, or ICS); ANORO ELLIPTA, a medication that pairs umeclidinium bromide (a long-acting muscarinic antagonist, or LAMA) with vilanterol (LABA); and TRELEGY ELLIPTA, a comprehensive treatment combining an ICS, LAMA, and LABA. The company has forged a key strategic alliance with Sarissa Capital Management LP. Moreover, Innoviva collaborates with Glaxo Group Limited under an agreement focused on the development and commercialization of daily LABA-based products designed to treat chronic obstructive pulmonary disease and asthma. Founded in 1996, the corporation was initially known as Theravance, Inc., before officially changing its name to Innoviva, Inc. in January 2016. Its primary operational base is situated in Burlingame, California.

Burlingame, CA

159 employees

www.inva.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: Pavel Raifeld

View full financials

Quarterly Report	TTM	Quarter ended Jun 2026	Quarter ended Mar 2026	Quarter ended Dec 2025	Quarter ended Sep 2025	Quarter ended Jun 2025	Quarter ended Mar 2025	Quarter ended Dec 2024	Quarter ended Sep 2024
Total Current Assets	753.37M	753.37M	772.62M	727.51M	684.57M	651.78M	582.02M	554.31M	400.62M
Cash & Cash Equivalents	570.39M	570.39M	603.09M	550.94M	476.51M	397.53M	319.09M	304.96M	260.63M
Short-Term Investments	8.67M	8.67M	8.85M	0.00	56.59M	100.20M	127.79M	107.53M	0.00
Cash & Short-Term Investments	579.06M	579.06M	611.93M	550.94M	533.10M	497.73M	446.88M	412.50M	260.63M
Accounts Receivable	110.62M	110.62M	92.63M	34.97M	93.52M	88.26M	77.94M	86.37M	91.06M
Inventory	38.97M	38.97M	38.84M	39.17M	38.36M	49.00M	41.48M	33.73M	34.24M
Total Assets	1.70B	1.70B	1.84B	1.64B	1.43B	1.33B	1.25B	1.30B	1.23B
Property, Plant & Equipment	12.51M	12.51M	12.79M	12.48M	2.93M	2.21M	2.59M	2.97M	3.33M
Goodwill	17.91M	17.91M	17.91M	17.91M	17.91M	17.91M	17.91M	17.91M	17.91M
Intangible Assets	168.98M	168.98M	175.60M	182.16M	186.19M	195.41M	201.96M	208.43M	210.94M
Long-Term Investments	660.85M	660.85M	764.45M	193.73M	426.37M	349.11M	329.84M	393.96M	507.72M
Total Current Liabilities	47.06M	47.06M	36.56M	49.70M	48.47M	246.56M	234.75M	236.08M	223.75M
Accounts Payable	4.02M	4.02M	6.52M	4.97M	6.24M	5.38M	4.70M	2.13M	4.17M
Short-Term Debt	0.00	0.00	5.34M	0.00	7.74M	191.90M	192.22M	192.03M	191.84M
Total Liabilities	469.46M	469.46M	494.93M	462.32M	419.15M	618.75M	607.49M	609.90M	563.07M
Long-Term Debt	258.45M	258.45M	315.39M	257.73M	313.90M	257.02M	256.67M	256.32M	255.97M
Total Debt	269.66M	269.66M	331.42M	269.02M	323.23M	450.90M	451.26M	451.10M	450.91M
Net Debt (Cash)	-300.73M	-300.73M	-271.67M	-281.92M	-153.28M	53.37M	132.17M	146.13M	190.28M
Total Shareholders' Equity	1.23B	1.23B	1.34B	1.17B	1.01B	714.82M	646.90M	691.16M	668.54M
Common Stock	727K	727K	738K	747K	748K	630K	628K	627K	626K
Retained Earnings	372.54M	372.54M	455.96M	269.37M	105.22M	15.31M	-48.38M	-1.80M	-22.13M
Current Ratio	16.01	16.01	21.13	14.64	14.12	2.64	2.48	2.35	1.79
Debt to Equity Ratio	0.22	0.22	0.25	0.23	0.32	0.63	0.70	0.65	0.67

Quarterly Report

TTM

Quarter ended Jun 2026

Quarter ended Mar 2026

Quarter ended Dec 2025

Quarter ended Sep 2025

Quarter ended Jun 2025

Quarter ended Mar 2025

Quarter ended Dec 2024

Quarter ended Sep 2024

Total Current Assets

753.37M

772.62M

727.51M

684.57M

651.78M

582.02M

554.31M

400.62M

Cash & Cash Equivalents

570.39M

603.09M

550.94M

476.51M

397.53M

319.09M

304.96M

260.63M

Short-Term Investments

8.67M

8.85M

0.00

56.59M

100.20M

127.79M

107.53M

0.00

Cash & Short-Term Investments

579.06M

611.93M

550.94M

533.10M

497.73M

446.88M

412.50M

260.63M

Accounts Receivable

110.62M

92.63M

34.97M

93.52M

88.26M

77.94M

86.37M

91.06M

Inventory

38.97M

38.84M

39.17M

38.36M

49.00M

41.48M

33.73M

34.24M

Total Assets

1.70B

1.84B

1.64B

1.43B

1.33B

1.25B

1.30B

1.23B

Property, Plant & Equipment

12.51M

12.79M

12.48M

2.93M

2.21M

2.59M

2.97M

3.33M

Goodwill

17.91M

Intangible Assets

168.98M

175.60M

182.16M

186.19M

195.41M

201.96M

208.43M

210.94M

Long-Term Investments

660.85M

764.45M

193.73M

426.37M

349.11M

329.84M

393.96M

507.72M

Total Current Liabilities

47.06M

36.56M

49.70M

48.47M

246.56M

234.75M

236.08M

223.75M

Accounts Payable

4.02M

6.52M

4.97M

6.24M

5.38M

4.70M

2.13M

4.17M

Short-Term Debt

0.00

5.34M

0.00

7.74M

191.90M

192.22M

192.03M

191.84M

Total Liabilities

469.46M

494.93M

462.32M

419.15M

618.75M

607.49M

609.90M

563.07M

Long-Term Debt

258.45M

315.39M

257.73M

313.90M

257.02M

256.67M

256.32M

255.97M

Total Debt

269.66M

331.42M

269.02M

323.23M

450.90M

451.26M

451.10M

450.91M

Net Debt (Cash)

-300.73M

-271.67M

-281.92M

-153.28M

53.37M

132.17M

146.13M

190.28M

Total Shareholders' Equity

1.23B

1.34B

1.17B

1.01B

714.82M

646.90M

691.16M

668.54M

Common Stock

727K

738K

747K

748K

630K

628K

627K

626K

Retained Earnings

372.54M

455.96M

269.37M

105.22M

15.31M

-48.38M

-1.80M

-22.13M

Current Ratio

16.01

21.13

14.64

14.12

2.64

2.48

2.35

1.79

Debt to Equity Ratio

0.22

0.25

0.23

0.32

0.63

0.70

0.65

0.67

Annual Report	12/31/2025	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018
Total Current Assets	727.51M	554.31M	344.22M	443.51M	313.67M	342.06M	431.23M	199.04M
Cash & Cash Equivalents	550.94M	304.96M	193.51M	291.05M	201.53M	246.49M	278.10M	62.42M
Short-Term Investments	0.00	107.53M	0.00	0.00	0.00	0.00	72.75M	52.49M
Cash & Short-Term Investments	550.94M	412.50M	193.51M	291.05M	201.53M	246.49M	350.85M	114.91M
Accounts Receivable	34.97M	86.37M	84.08M	64.07M	110.71M	93.93M	79.43M	83.29M
Inventory	39.17M	33.73M	40.74M	55.90M	0.00	0.00	0.00	0.00
Total Assets	1.64B	1.30B	1.24B	1.23B	926.39M	999.57M	724.83M	548.19M
Property, Plant & Equipment	12.48M	2.97M	3.02M	3.44M	109K	28K	33K	160K
Goodwill	17.91M	17.91M	17.91M	26.71M	0.00	0.00	0.00	0.00
Intangible Assets	182.16M	208.43M	230.34M	252.92M	0.00	0.00	0.00	0.00
Long-Term Investments	193.73M	393.96M	560.98M	403.01M	483.85M	438.26M	0.00	0.00
Total Current Liabilities	49.70M	236.08M	38.13M	134.97M	5.81M	6.11M	5.37M	5.70M
Accounts Payable	4.97M	2.13M	6.72M	2.94M	27K	66K	10K	11K
Short-Term Debt	0.00	192.03M	0.00	96.19M	0.00	0.00	0.00	0.00
Total Liabilities	462.32M	609.90M	568.55M	665.71M	400.46M	391.73M	382.71M	389.14M
Long-Term Debt	257.73M	256.32M	446.23M	444.18M	394.65M	385.52M	377.12M	382.86M
Total Debt	269.02M	451.10M	449.08M	544.07M	394.76M	385.52M	377.12M	382.86M
Net Debt (Cash)	-281.92M	146.13M	255.56M	253.02M	193.23M	139.03M	99.02M	320.44M
Total Shareholders' Equity	1.17B	691.16M	674.96M	565.79M	414.74M	539.91M	313.50M	153.58M
Common Stock	747K	627K	633K	692K	696K	1.01M	1.01M	1.01M
Retained Earnings	269.37M	-1.80M	-25.19M	-204.91M	-456.15M	-722.00M	-946.40M	-1.10B
Current Ratio	14.64	2.35	9.03	3.29	54.02	55.98	80.29	34.92
Debt to Equity Ratio	0.23	0.65	0.67	0.96	0.95	0.71	1.20	2.49

Annual Report

12/31/2025

12/31/2024

12/31/2023

12/31/2022

12/31/2021

12/31/2020

12/31/2019

12/31/2018

Total Current Assets

727.51M

554.31M

344.22M

443.51M

313.67M

342.06M

431.23M

199.04M

Cash & Cash Equivalents

550.94M

304.96M

193.51M

291.05M

201.53M

246.49M

278.10M

62.42M

Short-Term Investments

0.00

107.53M

0.00

72.75M

52.49M

Cash & Short-Term Investments

550.94M

412.50M

193.51M

291.05M

201.53M

246.49M

350.85M

114.91M

Accounts Receivable

34.97M

86.37M

84.08M

64.07M

110.71M

93.93M

79.43M

83.29M

Inventory

39.17M

33.73M

40.74M

55.90M

0.00

Total Assets

1.64B

1.30B

1.24B

1.23B

926.39M

999.57M

724.83M

548.19M

Property, Plant & Equipment

12.48M

2.97M

3.02M

3.44M

109K

28K

33K

160K

Goodwill

17.91M

26.71M

0.00

Intangible Assets

182.16M

208.43M

230.34M

252.92M

0.00

Long-Term Investments

193.73M

393.96M

560.98M

403.01M

483.85M

438.26M

0.00

Total Current Liabilities

49.70M

236.08M

38.13M

134.97M

5.81M

6.11M

5.37M

5.70M

Accounts Payable

4.97M

2.13M

6.72M

2.94M

27K

66K

10K

11K

Short-Term Debt

0.00

192.03M

0.00

96.19M

0.00

Total Liabilities

462.32M

609.90M

568.55M

665.71M

400.46M

391.73M

382.71M

389.14M

Long-Term Debt

257.73M

256.32M

446.23M

444.18M

394.65M

385.52M

377.12M

382.86M

Total Debt

269.02M

451.10M

449.08M

544.07M

394.76M

385.52M

377.12M

382.86M

Net Debt (Cash)

-281.92M

146.13M

255.56M

253.02M

193.23M

139.03M

99.02M

320.44M

Total Shareholders' Equity

1.17B

691.16M

674.96M

565.79M

414.74M

539.91M

313.50M

153.58M

Common Stock

747K

627K

633K

692K

696K

1.01M

Retained Earnings

269.37M

-1.80M

-25.19M

-204.91M

-456.15M

-722.00M

-946.40M

-1.10B

Current Ratio

14.64

2.35

9.03

3.29

54.02

55.98

80.29

34.92

Debt to Equity Ratio

0.23

0.65

0.67

0.96

0.95

0.71

1.20

2.49

Balance Sheet

Quarterly Balance Sheet (USD)

Annual Balance Sheet (USD)